HEADER TRANSFERASE 10-JAN-19 6QG4 TITLE STRUCTURE OF THE MITOGEN ACTIVATED KINASE KINASE 7 IN COMPLEX WITH TITLE 2 PYRAZOLOPYRIMIDINE INHIBITOR 1H COMPND MOL_ID: 1; COMPND 2 MOLECULE: DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 7; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MAPKK 7,JNK-ACTIVATING KINASE 2,MAPK/ERK KINASE 7,MEK 7, COMPND 5 STRESS-ACTIVATED PROTEIN KINASE KINASE 4,SAPKK4,C-JUN N-TERMINAL COMPND 6 KINASE KINASE 2,JNKK 2; COMPND 7 EC: 2.7.12.2; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAP2K7, JNKK2, MEK7, MKK7, PRKMK7, SKK4; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS PROTEIN KINASE, KINASE, MKK7, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR P.WOLLE,M.P.MUELLER,D.RAUH REVDAT 5 24-JAN-24 6QG4 1 REMARK REVDAT 4 26-JUN-19 6QG4 1 JRNL REVDAT 3 12-JUN-19 6QG4 1 JRNL REVDAT 2 29-MAY-19 6QG4 1 JRNL REVDAT 1 22-MAY-19 6QG4 0 JRNL AUTH P.WOLLE,J.ENGEL,S.SMITH,L.GOEBEL,E.HENNES,J.LATEGAHN,D.RAUH JRNL TITL CHARACTERIZATION OF COVALENT PYRAZOLOPYRIMIDINE-MKK7 JRNL TITL 2 COMPLEXES AND A REPORT ON A UNIQUE DFG-IN/LEU-IN JRNL TITL 3 CONFORMATION OF MITOGEN-ACTIVATED PROTEIN KINASE KINASE 7 JRNL TITL 4 (MKK7). JRNL REF J.MED.CHEM. V. 62 5541 2019 JRNL REFN ISSN 0022-2623 JRNL PMID 31083997 JRNL DOI 10.1021/ACS.JMEDCHEM.9B00472 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.14_3260: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.05 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 16020 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.237 REMARK 3 R VALUE (WORKING SET) : 0.234 REMARK 3 FREE R VALUE : 0.269 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1121 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 43.0575 - 4.5984 1.00 1981 149 0.2064 0.2250 REMARK 3 2 4.5984 - 3.6505 1.00 1894 142 0.1998 0.2360 REMARK 3 3 3.6505 - 3.1892 1.00 1840 139 0.2528 0.2876 REMARK 3 4 3.1892 - 2.8977 1.00 1854 139 0.2781 0.3104 REMARK 3 5 2.8977 - 2.6901 1.00 1845 139 0.2864 0.3494 REMARK 3 6 2.6901 - 2.5315 1.00 1836 138 0.2918 0.3569 REMARK 3 7 2.5315 - 2.4047 1.00 1813 137 0.3053 0.3813 REMARK 3 8 2.4047 - 2.3000 1.00 1836 138 0.3304 0.4068 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.400 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 33.210 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 2116 REMARK 3 ANGLE : 0.491 2866 REMARK 3 CHIRALITY : 0.040 326 REMARK 3 PLANARITY : 0.003 363 REMARK 3 DIHEDRAL : 2.921 1255 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6QG4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 10-JAN-19. REMARK 100 THE DEPOSITION ID IS D_1292100015. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-MAR-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16030 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 43.050 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 13.05 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06000 REMARK 200 FOR THE DATA SET : 21.7700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.40 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 12.79 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 1.20000 REMARK 200 FOR SHELL : 2.280 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2DYL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.79 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M SODIUMCITRATE 0.2% PEG3350, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 30.10000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 43.05000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.50000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 43.05000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 30.10000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 33.50000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12970 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 107 REMARK 465 GLY A 108 REMARK 465 HIS A 109 REMARK 465 HIS A 110 REMARK 465 HIS A 111 REMARK 465 HIS A 112 REMARK 465 HIS A 113 REMARK 465 HIS A 114 REMARK 465 SER A 115 REMARK 465 ALA A 116 REMARK 465 LYS A 117 REMARK 465 GLY A 125 REMARK 465 SER A 144 REMARK 465 GLY A 145 REMARK 465 THR A 146 REMARK 465 CYS A 147 REMARK 465 GLY A 148 REMARK 465 LEU A 284 REMARK 465 VAL A 285 REMARK 465 ASP A 286 REMARK 465 SER A 287 REMARK 465 LYS A 288 REMARK 465 ALA A 289 REMARK 465 LYS A 290 REMARK 465 THR A 291 REMARK 465 ARG A 292 REMARK 465 SER A 293 REMARK 465 ALA A 294 REMARK 465 GLY A 295 REMARK 465 CYS A 296 REMARK 465 PRO A 308 REMARK 465 ASP A 309 REMARK 465 PRO A 310 REMARK 465 THR A 311 REMARK 465 LYS A 312 REMARK 465 PRO A 313 REMARK 465 ASP A 314 REMARK 465 TYR A 315 REMARK 465 ASP A 316 REMARK 465 GLU A 418 REMARK 465 SER A 419 REMARK 465 PRO A 420 REMARK 465 ARG A 421 REMARK 465 THR A 422 REMARK 465 SER A 423 REMARK 465 GLY A 424 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 118 CG CD OE1 NE2 REMARK 470 TYR A 121 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ILE A 124 CG1 CG2 CD1 REMARK 470 GLN A 127 CG CD OE1 NE2 REMARK 470 ARG A 128 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 130 CG CD OE1 NE2 REMARK 470 LYS A 157 CG CD CE NZ REMARK 470 LYS A 173 CG CD CE NZ REMARK 470 GLU A 174 CG CD OE1 OE2 REMARK 470 LYS A 177 CG CD CE NZ REMARK 470 GLN A 197 CG CD OE1 NE2 REMARK 470 ASN A 205 CG OD1 ND2 REMARK 470 LYS A 250 CG CD CE NZ REMARK 470 GLU A 251 CG CD OE1 OE2 REMARK 470 LYS A 252 CG CD CE NZ REMARK 470 ARG A 258 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 270 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 283 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 303 CG CD OE1 OE2 REMARK 470 ARG A 304 CG CD NE CZ NH1 NH2 REMARK 470 ILE A 305 CG1 CG2 CD1 REMARK 470 ILE A 317 CG1 CG2 CD1 REMARK 470 LYS A 339 CG CD CE NZ REMARK 470 LEU A 348 CG CD1 CD2 REMARK 470 GLU A 355 CG CD OE1 OE2 REMARK 470 ARG A 382 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 383 CG CD CE NZ REMARK 470 LYS A 386 CG CD CE NZ REMARK 470 LYS A 389 CG CD CE NZ REMARK 470 GLU A 392 CG CD OE1 OE2 REMARK 470 LYS A 397 CG CD CE NZ REMARK 470 GLU A 403 CG CD OE1 OE2 REMARK 470 ASP A 412 CG OD1 OD2 REMARK 470 LYS A 416 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 189 43.19 -100.82 REMARK 500 ASP A 259 50.13 -166.99 REMARK 500 LEU A 377 31.39 -96.79 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue J0E A 501 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6QFL RELATED DB: PDB REMARK 900 RELATED ID: 6QFR RELATED DB: PDB REMARK 900 RELATED ID: 6QFT RELATED DB: PDB DBREF 6QG4 A 127 424 UNP O14733 MP2K7_HUMAN 154 451 SEQADV 6QG4 MET A 107 UNP O14733 INITIATING METHIONINE SEQADV 6QG4 GLY A 108 UNP O14733 EXPRESSION TAG SEQADV 6QG4 HIS A 109 UNP O14733 EXPRESSION TAG SEQADV 6QG4 HIS A 110 UNP O14733 EXPRESSION TAG SEQADV 6QG4 HIS A 111 UNP O14733 EXPRESSION TAG SEQADV 6QG4 HIS A 112 UNP O14733 EXPRESSION TAG SEQADV 6QG4 HIS A 113 UNP O14733 EXPRESSION TAG SEQADV 6QG4 HIS A 114 UNP O14733 EXPRESSION TAG SEQADV 6QG4 SER A 115 UNP O14733 EXPRESSION TAG SEQADV 6QG4 ALA A 116 UNP O14733 EXPRESSION TAG SEQADV 6QG4 LYS A 117 UNP O14733 EXPRESSION TAG SEQADV 6QG4 GLN A 118 UNP O14733 EXPRESSION TAG SEQADV 6QG4 THR A 119 UNP O14733 EXPRESSION TAG SEQADV 6QG4 GLY A 120 UNP O14733 EXPRESSION TAG SEQADV 6QG4 TYR A 121 UNP O14733 EXPRESSION TAG SEQADV 6QG4 LEU A 122 UNP O14733 EXPRESSION TAG SEQADV 6QG4 THR A 123 UNP O14733 EXPRESSION TAG SEQADV 6QG4 ILE A 124 UNP O14733 EXPRESSION TAG SEQADV 6QG4 GLY A 125 UNP O14733 EXPRESSION TAG SEQADV 6QG4 GLY A 126 UNP O14733 EXPRESSION TAG SEQRES 1 A 318 MET GLY HIS HIS HIS HIS HIS HIS SER ALA LYS GLN THR SEQRES 2 A 318 GLY TYR LEU THR ILE GLY GLY GLN ARG TYR GLN ALA GLU SEQRES 3 A 318 ILE ASN ASP LEU GLU ASN LEU GLY GLU MET GLY SER GLY SEQRES 4 A 318 THR CYS GLY GLN VAL TRP LYS MET ARG PHE ARG LYS THR SEQRES 5 A 318 GLY HIS VAL ILE ALA VAL LYS GLN MET ARG ARG SER GLY SEQRES 6 A 318 ASN LYS GLU GLU ASN LYS ARG ILE LEU MET ASP LEU ASP SEQRES 7 A 318 VAL VAL LEU LYS SER HIS ASP CYS PRO TYR ILE VAL GLN SEQRES 8 A 318 CYS PHE GLY THR PHE ILE THR ASN THR ASP VAL PHE ILE SEQRES 9 A 318 ALA MET GLU LEU MET GLY THR CYS ALA GLU LYS LEU LYS SEQRES 10 A 318 LYS ARG MET GLN GLY PRO ILE PRO GLU ARG ILE LEU GLY SEQRES 11 A 318 LYS MET THR VAL ALA ILE VAL LYS ALA LEU TYR TYR LEU SEQRES 12 A 318 LYS GLU LYS HIS GLY VAL ILE HIS ARG ASP VAL LYS PRO SEQRES 13 A 318 SER ASN ILE LEU LEU ASP GLU ARG GLY GLN ILE LYS LEU SEQRES 14 A 318 CYS ASP PHE GLY ILE SER GLY ARG LEU VAL ASP SER LYS SEQRES 15 A 318 ALA LYS THR ARG SER ALA GLY CYS ALA ALA TYR MET ALA SEQRES 16 A 318 PRO GLU ARG ILE ASP PRO PRO ASP PRO THR LYS PRO ASP SEQRES 17 A 318 TYR ASP ILE ARG ALA ASP VAL TRP SER LEU GLY ILE SER SEQRES 18 A 318 LEU VAL GLU LEU ALA THR GLY GLN PHE PRO TYR LYS ASN SEQRES 19 A 318 CYS LYS THR ASP PHE GLU VAL LEU THR LYS VAL LEU GLN SEQRES 20 A 318 GLU GLU PRO PRO LEU LEU PRO GLY HIS MET GLY PHE SER SEQRES 21 A 318 GLY ASP PHE GLN SER PHE VAL LYS ASP CYS LEU THR LYS SEQRES 22 A 318 ASP HIS ARG LYS ARG PRO LYS TYR ASN LYS LEU LEU GLU SEQRES 23 A 318 HIS SER PHE ILE LYS ARG TYR GLU THR LEU GLU VAL ASP SEQRES 24 A 318 VAL ALA SER TRP PHE LYS ASP VAL MET ALA LYS THR GLU SEQRES 25 A 318 SER PRO ARG THR SER GLY HET J0E A 501 27 HETNAM J0E 1-[(3~{R})-3-[4-AZANYL-3-(4-HYDROXYPHENYL)PYRAZOLO[3,4- HETNAM 2 J0E D]PYRIMIDIN-1-YL]PIPERIDIN-1-YL]PROPAN-1-ONE FORMUL 2 J0E C19 H22 N6 O2 FORMUL 3 HOH *40(H2 O) HELIX 1 AA1 GLU A 132 ASN A 134 5 3 HELIX 2 AA2 ASN A 172 SER A 189 1 18 HELIX 3 AA3 ALA A 219 GLN A 227 1 9 HELIX 4 AA4 PRO A 231 HIS A 253 1 23 HELIX 5 AA5 LYS A 261 SER A 263 5 3 HELIX 6 AA6 ALA A 301 ASP A 306 1 6 HELIX 7 AA7 ARG A 318 GLY A 334 1 17 HELIX 8 AA8 THR A 343 GLU A 354 1 12 HELIX 9 AA9 SER A 366 LEU A 377 1 12 HELIX 10 AB1 LYS A 386 LEU A 391 1 6 HELIX 11 AB2 HIS A 393 LEU A 402 1 10 HELIX 12 AB3 ASP A 405 LYS A 416 1 12 SHEET 1 AA1 2 TYR A 121 THR A 123 0 SHEET 2 AA1 2 ARG A 128 GLN A 130 -1 O TYR A 129 N LEU A 122 SHEET 1 AA2 5 LEU A 136 GLU A 141 0 SHEET 2 AA2 5 VAL A 150 PHE A 155 -1 O LYS A 152 N LEU A 139 SHEET 3 AA2 5 VAL A 161 ARG A 168 -1 O VAL A 164 N TRP A 151 SHEET 4 AA2 5 ASP A 207 MET A 212 -1 O MET A 212 N ALA A 163 SHEET 5 AA2 5 CYS A 198 ILE A 203 -1 N PHE A 202 O PHE A 209 SHEET 1 AA3 3 THR A 217 CYS A 218 0 SHEET 2 AA3 3 ILE A 265 LEU A 267 -1 O LEU A 267 N THR A 217 SHEET 3 AA3 3 ILE A 273 LEU A 275 -1 O LYS A 274 N LEU A 266 LINK SG CYS A 218 C9 J0E A 501 1555 1555 1.76 SITE 1 AC1 10 MET A 142 LYS A 165 ASP A 182 MET A 212 SITE 2 AC1 10 GLU A 213 MET A 215 CYS A 218 LYS A 221 SITE 3 AC1 10 SER A 263 HOH A 601 CRYST1 60.200 67.000 86.100 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016611 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014925 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011614 0.00000